Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00053
Species: Homo sapiens
Position : chr17:38065500-38067500
Year: 2016
Title: 17q21 asthma-risk variants switch CTCF binding and regulate IL-2 production by T cells.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: asthma
PMID:  27848966
MONDO: MONDO:0004979
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: HuT 78
CVCL ID: CVCL_0337
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay; Chromatin interaction assay; Disease-variant functional analysis
High Throughput Method: ATAC-seq, ChIP-seq, 4C-seq, RNA-seq, DNase-seq; 4C-seq
Low Throughput Method: ChIP-RT-qPCR, Luciferase reporter assay, RT-RT-qPCR, siRNA knockdown, EMSA; 4C
About Target Gene
Target gene : ORMDL3
About TF
TF name : CTCF
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
CTCF Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
CTCF TGF_beta_Receptor netpath 220
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_00424 chr17:38065000-38068000 blood CD4-positive T cell NA
Expression of Target Genes for the Enhancer